Oct 21 (Reuters) - Molecular testing company Qiagen said on Wednesday Swedish buyout firm EQT would acquire it for about €9.6 billion ($10.78 billion). EQT offered €46.50 ($52.22) a share for Qiagen, representing an 8.6% premium to its last clo...